111 related articles for article (PubMed ID: 2086450)
1. A monoclonal antibody against the human IL-2 receptor binds to paraformaldehyde-fixed but not viable frog (Xenopus) splenocytes.
Haynes L; Moynihan JA; Cohen N
Immunol Lett; 1990 Dec; 26(3):227-32. PubMed ID: 2086450
[TBL] [Abstract][Full Text] [Related]
2. A monoclonal mouse anti-human IL-2 receptor antibody (anti-Tac) will recognize molecules on the surface of Xenopus laevis immunocytes which specifically bind rIL-2 and are only slightly larger than the human Tac protein.
Ruben LN; Langeberg L; Malley A; Clothier RH; Beadling C; Lee R; Shiigi S
Immunol Lett; 1990 May; 24(2):117-25. PubMed ID: 2354864
[TBL] [Abstract][Full Text] [Related]
3. Loss of antibody binding to prefixed cells: fixation parameters for immunocytochemistry.
Van Ewijk W; Van Soest PL; Verkerk A; Jongkind JF
Histochem J; 1984 Feb; 16(2):179-93. PubMed ID: 6421777
[TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody 7G7/B6, binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac.
Rubin LA; Kurman CC; Biddison WE; Goldman ND; Nelson DL
Hybridoma; 1985; 4(2):91-102. PubMed ID: 2408992
[TBL] [Abstract][Full Text] [Related]
5. Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteins.
Pollice AA; McCoy JP; Shackney SE; Smith CA; Agarwal J; Burholt DR; Janocko LE; Hornicek FJ; Singh SG; Hartsock RJ
Cytometry; 1992; 13(4):432-44. PubMed ID: 1382010
[TBL] [Abstract][Full Text] [Related]
6. The characteristics of a monoclonal antibody that binds specifically to rat T lymphoblasts and inhibits IL 2 receptor functions.
Osawa H; Diamantstein T
J Immunol; 1983 Jan; 130(1):51-5. PubMed ID: 6401187
[TBL] [Abstract][Full Text] [Related]
7. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
8. Toad splenocytes bind human IL-2 and anti-human IL-2 receptor antibody specifically.
Langeberg L; Ruben LN; Malley A; Shiigi S; Beadling C
Immunol Lett; 1987 Jan; 14(2):103-10. PubMed ID: 3108143
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD3:anti-IL-2 receptor bispecific monoclonal antibody. Targeting of activated T cells in vitro.
MacLean JA; Su Z; Guo Y; Sy MS; Colvin RB; Wong JT
J Immunol; 1993 Feb; 150(4):1619-28. PubMed ID: 8432997
[TBL] [Abstract][Full Text] [Related]
10. Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18.
Mouzaki A; Volk HD; Osawa H; Diamantstein T
Eur J Immunol; 1987 Mar; 17(3):335-41. PubMed ID: 3106058
[TBL] [Abstract][Full Text] [Related]
11. Functional responses of T cells blocked by anti-CD25 antibody therapy during cardiac rejection.
Baan CC; van Gelder T; Balk AH; Knoop CJ; Holweg CT; Maat LP; Weimar W
Transplantation; 2000 Feb; 69(3):331-6. PubMed ID: 10706038
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2 blocks the antitumour activity caused by depletion of CD25 cells in a murine renal adenocarcinoma model.
Takeuchi T; Konno-Takahashi N; Kasuya Y; Ogushi T; Nishimatsu H; Kitamura T
BJU Int; 2004 Jul; 94(1):171-6. PubMed ID: 15217455
[TBL] [Abstract][Full Text] [Related]
13. Differential ability of fixed antigen-presenting cells to stimulate nominal antigen-reactive and alloreactive T4 lymphocytes.
Moreno J; Lipsky PE
J Immunol; 1986 May; 136(10):3579-87. PubMed ID: 3084635
[TBL] [Abstract][Full Text] [Related]
14. Immunoelectron microscopic identification of human NK cells by FITC-conjugated anti-Leu-11a and biotinylated anti-Leu-7 antibodies.
Kang YH; Carl M; Watson LP; Yaffe L
J Immunol Methods; 1985 Nov; 84(1-2):177-96. PubMed ID: 3934284
[TBL] [Abstract][Full Text] [Related]
15. The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells.
Ortega G; Robb RJ; Shevach EM; Malek TR
J Immunol; 1984 Oct; 133(4):1970-5. PubMed ID: 6206144
[TBL] [Abstract][Full Text] [Related]
16. Immunogenic epitopes of the p55 chain of the IL-2 receptor. Relationships to high-affinity IL-2 binding and modulation of the p55 chain.
Wong JT; Schott E; Sabga EM; Kielpinski GG; Colvin RB
Transplantation; 1990 Mar; 49(3):587-96. PubMed ID: 1690471
[TBL] [Abstract][Full Text] [Related]
17. T-independent and T-dependent B lymphoblasts: helper T cells prime for interleukin 2-induced growth and secretion of immunoglobulins that utilize downstream heavy chains.
Forman MS; Puré E
J Exp Med; 1991 Mar; 173(3):687-97. PubMed ID: 1825505
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of human lymphocyte proliferative response to purified protein derivative by an anti-interleukin-2 receptor alpha chain antibody (CD25).
Kasinrerk W; Majdic O; Praputpittaya K; Sittisombut N
Immunology; 1994 Sep; 83(1):33-7. PubMed ID: 7821963
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-activated Xenopus laevis lymphocytes produce a T-cell growth factor.
Watkins D; Cohen N
Immunology; 1987 Sep; 62(1):119-25. PubMed ID: 2958404
[TBL] [Abstract][Full Text] [Related]
20. IL-2 linked to a peptide from influenza hemagglutinin enhances T cell activation by affecting the antigen-presentation function of bone marrow-derived dendritic cells.
Faulkner L; Buchan G; Lockhart E; Slobbe L; Wilson M; Baird M
Int Immunol; 2001 Jun; 13(6):713-21. PubMed ID: 11369698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
